Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
30 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year.
FDA Lifts Clinical Hold On Allogene’s CAR-T Trials
The FDA has lifted the hold on Cellectis SA's (NASDAQ:
21 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from NYSE regarding delayed Form 20-F filing.
Cellectis’ Licensed Partner, Allogene Therapeutics, Announces Removal Of FDA Clinical Hold On Their Clinical Trials
Cellectis (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today stated that its licensed partner, Allogene
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound.